Sinocelltech Ltd.

This study tests an experimental drug called SCT650C in 60 adults with moderate to severe hidradenitis suppurativa (HS), a painful skin condition causing boils and tunnels. The goal is to see if the drug can reduce abscesses and inflammation by at least 75% after 16 weeks. Partic…

This study tests whether adding the experimental drug SCTC21C to standard chemotherapy (VCd) works better than standard chemotherapy alone for people newly diagnosed with AL amyloidosis, a rare disease where abnormal proteins build up in organs. About 90 adults with measurable di…

This study tests a new medicine called SCT520FF for people with neovascular age-related macular degeneration (nAMD), a condition that can cause rapid vision loss. The trial will include 82 adults aged 45 to 80 and aims to check the drug's safety and how well it works. Researchers…

This study tests whether adding an experimental drug called SCTC21C to a standard three-drug regimen can help people with newly diagnosed multiple myeloma who cannot have a stem cell transplant. The goal is to see if the combination can keep the cancer from coming back longer and…

This study tests a new drug called SCTB14 against the standard drug pembrolizumab for people with advanced non-small cell lung cancer that has not been treated yet. About 246 adults with a specific tumor marker (TPS ≥10%) will receive either SCTB14 or pembrolizumab to see which o…

This study is testing a new medicine called SCT800 to prevent bleeding episodes in people with severe hemophilia A who have not been treated before. The goal is to see if regular infusions of SCT800 can safely reduce the number of bleeds. About 36 male participants will receive t…